Full text
71,946 characters
· extracted from
preprint-html
· click to expand
Altered plasma metabolites as fingerprint of cardiac bypass surgery | medRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search Altered plasma metabolites as fingerprint of cardiac bypass surgery Frieder Neu , Max Wacker , Sven Schuchardt , Sam Vargese , View ORCID Profile George Awad , Jens Wippermann , Frank Peßler , Priya Veluswamy doi: https://doi.org/10.1101/2025.04.11.25325708 Frieder Neu 1 Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between Hannover Medical School and the Helmholtz Centre for Infection Research , Braunschweig, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site Max Wacker 2 Heart Surgery Research, Department of Cardiothoracic Surgery, Otto-von-Guericke University Hospital , Magdeburg, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sven Schuchardt 3 Department of Bio and Environmental Analytics, Fraunhofer Institute for Toxicology and Environmental Medicine , Hannover, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sam Vargese 2 Heart Surgery Research, Department of Cardiothoracic Surgery, Otto-von-Guericke University Hospital , Magdeburg, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site George Awad 2 Heart Surgery Research, Department of Cardiothoracic Surgery, Otto-von-Guericke University Hospital , Magdeburg, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for George Awad Jens Wippermann 2 Heart Surgery Research, Department of Cardiothoracic Surgery, Otto-von-Guericke University Hospital , Magdeburg, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site Frank Peßler 1 Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between Hannover Medical School and the Helmholtz Centre for Infection Research , Braunschweig, Germany 4 Centre for Individualised Infection Medicine , Hannover, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site Priya Veluswamy 2 Heart Surgery Research, Department of Cardiothoracic Surgery, Otto-von-Guericke University Hospital , Magdeburg, Germany Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: Priya.Veluswamy{at}med.ovgu.de Abstract Full Text Info/History Metrics Data/Code Preview PDF ABSTRACT Aims Cardiac surgery leads to major post-operative changes in metabolism, but their exact nature and the underlying risk factors remains obscure. We aimed to characterize changes in plasma metabolites after coronary artery bypass grafting (CABG) to identify intra- and post-operative risk factors for global and specific alterations in plasma metabolites post-operatively. Methods We performed a targeted metabolomic screen on plasma samples from patients undergoing on-pump CABG for coronary artery disease (CAD) (n=24), collected 1 day before surgery and on post-op days 1, 3, and 7. We assessed correlations with parameters of intra-operative course (cardiopulmonary bypass time and aortic cross-clamping time), intensive care unit (ICU) care, (length of ICU stay, duration of mechanical ventilation, duration of epinephrine/dobutamine or norepinephrine therapy), and systemic inflammation. Results Of the potentially detectable 1019 analytes, 970 passed the quality screen and were included in the analysis. With respect to d0, the greatest degree of change in metabolite populations occurred by d1, but substantial changes persisted through d7. Metabolites could be classified into those which were predominantly downregulated (e.g., triglycerides, bile acids, cholesterol esters, lysophosphatidylcholines, indoles and derivatives), up- or downregulated (e.g., phosphatidylinositol, phosphatidylethanolamines, phosphatidic acids, ceramides), or upregulated (free fatty acids, monoglycerides). Concentrations of food- and/or microbiota-derived metabolites (indole derivatives, trimethylamine N-oxide, trigonelline) were markedly reduced particularly on d1 and d3. Changes in metabolite concentrations correlated most strongly with plasma C-reactive protein concentration (r = -0.67 to 0.59) and blood leukocyte count (-0.63 to 0.32) and less with intra-operative (-0.62 to 0.5) and ICU care (-0.52 to 0.38) parameters. Of note, neither CRP nor leukocyte count correlated significantly with an intra-operative or ICU parameter. Conclusions These results reveal pronounced changes in plasma metabolite populations after CABG, which likely result from the combined effects of surgical and post-operative stress, systemic inflammation, reduced dietary intake, and changes in gut microflora. INTRODUCTION Despite advances in interventional therapies and medication, coronary artery bypass grafting (CABG) is still globally considered the gold standard for multivessel coronary artery disease (CAD). 1 This complex surgical procedure is usually conducted with cardiopulmonary bypass (CPB) using the heart-lung-machine (HLM). The major role of HLM is to support heart and lung function, maintaining blood circulation and oxygenation while heart beat is stopped for the duration of surgery. This is achieved by de-routing the blood through the tubes and membranes of the HLM, 2 where intimate contact between blood components (cellular and plasmatic fractions) and the non-endothelial surfaces of CPB and a subsequent post-CPB reperfusion injury could lead to aberrant blood cellular responses, i.e. by generating reactive oxygen and nitrogen species. 3 Such responses are associated with increased post-surgical systemic inflammation with a high likelihood for organ dysfunctions. Furthermore, traumatic incisions made during the surgical procedure are also considered key factors for acute systemic inflammation among these patients. 4 Though both traumatic surgical injury and CPB have been known to induce conventional pathological factors including complements, endotoxin release, cytokines, oxygen-free radicals, and platelet-activating factors, changes in small-molecule metabolite populations are now being increasingly appreciated as manifestations of distinct inflammatory endotypes. 5 Metabolic signatures in CAD provide rapid and systematic identification of small-molecule metabolites and distinct lipid metabolites, which are considered as “fingerprint” of an individual, in particular at the time of sampling. Indeed, altered cellular metabolism due to an underlying atherosclerotic pathological condition in CAD has been clearly evidenced by metabolic profiling in blood-based fluids. 6 Plasma lipidomics includes profiling of sterol lipids, glycerolipids, glycerophospholipids, and sphingolipids, which are considered the most abundant lipids. 7 Of note, both phosphatidylcholines (PC) and lysophosphatidylcholines (LPC) are important members of glycerophospholipids, where PC are integral molecules for (i) maintaining the structure of cell membrane and (ii) circulating lipoproteins and natural surfactants, and LPC is a hydrolyzed bioactive catabolite of PC. Both molecules play crucial roles in atherosclerosis development and progression. 8 Bile acids (BAs) are emerging as key metabolites in the context of cardiovascular health and disease, where they are originally synthesized in the liver and further metabolized by gut microbiota. 9 These BAs play pivotal roles in lipid metabolism, as well as in cardiovascular physiology upon signaling through the bile salt receptor (the farnesoid-X receptor (FXR)). 10 The BA-FXR signaling axis is known for its anti-atherosclerotic properties, by regulating lipid profiles and vascular tension, and thereby showing protective effects during atherogenesis. 11 , 12 Nevertheless, dysregulated BA levels could also contribute to cardiovascular pathologies. 13 This complexity is further underscored by research linking BAs with gut microbiota in the regulation of myocardial function. 14 Despite this, the exact mechanisms remain poorly understood, with some studies indicating that altered bile acid profiles, particularly the balance between primary and secondary BAs, may influence cardiac outcomes in heart disease. 15 Furthermore, clinical data suggest that serum concentration of BAs is inversely correlated with the presence of CAD and myocardial infarction, 16 highlighting the dual role of BAs in both protection and injury of cardiac tissue. Likewise, tryptophan (Trp) metabolism plays a significant role in cardiovascular physiology, where kynurenine, one of the Trp catabolites which breaks down further into several biologically active metabolites, 17 is now considered a biomarker for coronary artery disease. 18 , 19 Furthermore, Trp is also readily catabolized by intestinal microbiota to produce indole and derivatives thereof, including indoleacetic acid, indolealdehyde, indolepropionic acid, and indole sulfate. 20 Of note, indole derivatives are ligands for the aryl hydrocarbon receptor (AhR), and AhR signaling plays important roles in maintaining vascular homeostasis. 21 Most of these microbial-generated indole derivatives possess beneficial roles by (i) promoting tolerance; (ii) regulating mucosal integrity and gut permeability; (iii) promoting anticoagulant properties; (iv) ameliorating atherogenesis, showing their cardioprotective effects. 22 In contrast, indole sulfate accumulates as uremic toxin and therefore has a detrimental role in patients with vascular disease comorbid with chronic kidney failure. 23 , 24 Elevated levels of indole sulfate are involved in the pathogenesis of aortic arterial stiffness among CAD patients. 25 Though many studies show a causal relationship between blood metabolites and CAD progression, there are still major gaps in knowledge in identifying prominent metabolic signatures during surgery-related acute stress for a progressive time frame. Such metabolites could be regarded as biomarkers to predict postsurgical adverse events and CAD outcome. We therefore investigated the impact of cardiac surgery and the consequences of using CPB, on plasma metabolite alterations among CAD patients. Here, we analyzed CAD patients before surgery and followed them for three time points post CABG, to observe a possible link between alterations in plasma metabolites and systemic acute inflammation. Furthermore, we focused on associations between metabolic changes and several perioperative parameters including (i) CPB utilized time; (ii) aortic cross clamping time; (iii) mechanical ventilation time; (iv) epinephrine/dobutamine time; and (v) norepinephrine time. The results suggest that these metabolic indicators could serve as valuable molecular tools to identify disturbances in key metabolic pathways among CAD patients who have undergone CABG. METHODS Study cohort This prospective study was approved by the Ethics Committee of Otto-von-Guericke- University Hospital (OVGU, Magdeburg, Germany) (file no. 75/19), which is in accordance with the ethical principles of the Declaration of Helsinki. After giving informed consent, N=24 patients with coronary artery disease (CAD) from the Department of Cardiothoracic Surgery at OVGU were enrolled in 2023, all undergoing elective on-pump CABG. Among them, n=3 (12.5%) had two vessel disease, and n=21 (87.5%) had three vessel disease. Inclusion criteria were (i) adults >18 years of age and (ii) elective on-pump CABG. Exclusion criteria were (i) intake of immunosuppressive medication, (ii) viral hepatitis or HIV infection, and (iii) anemia with hemoglobin <7 mmol/l. All patients underwent the same standardized protocol for anesthesia (≥8 hours no food and ≥2 hours no beverage intake before surgery, general anesthesia with propofol, rocuronium and sufentanil), perfusion, and surgery. All patients resumed oral food intake on day 1 post-OP except for two patients who developed a complicated clinical course. Study design Blood samples were collected at the following time points: two days before surgery (d0, n=24), one day post-surgery (d1, n=24), three days post-surgery (d3, n=24), and either six (n=10) or seven days post-surgery (n=10). Due to early recovery, 10 patients were sampled on day 6 post-surgery before discharge to rehabilitation. A two-group comparison between day 6 and 7 post-surgery showed no significant separation in the principal component analysis (PCA) based on metabolic differences, and a differential abundance analysis (fold change ([FC]>|1.5|, false discovery rate [FDR] < 0.05) did not reveal any significantly changed metabolites. Thus, samples from day 6 and 7 post-surgery were collectively analyzed as day 7 (d7, n=20). Metabolite data were not available for 4 patients: one patient died on day 6 due to sudden cardiac death after transfer to normal ward, and the blood sample for metabolomic studies was not taken from 3 patients due to internal error. The data was paired, and each post-surgery sample (d1, d3, d7) was compared to the pre-surgery sample (d0) from the same patient. Blood and clinical parameters Plasma samples were obtained from venous blood and used for metabolite profiling. Blood was centrifuged to sediment cells and debris, and aliquots of supernatants were frozen at -80°C within 2 hours. Additionally, the following laboratory parameters were measured at each time point (d0, d1, d3 and d7) at the central laboratory of OVGU hospital using standard protocols: leukocyte count, C-reactive protein (CRP), alanine aminotransferase (ALAT), creatine kinase (CK), creatinine, quick, international normalized ratio (INR), and activated partial thrombin time (aPTT). Furthermore, the recorded surgical parameters comprised number of vessel bypasses, cardiopulmonary bypass time (CPB time), and aortic cross clamping time (ACC time). The intensive care unit (ICU) parameters that were recorded comprised length of ICU stay, time of total mechanical ventilation (MV time), and length of catecholamine therapy (epinephrine or dobutamine therapy [E/Dob time] and norepinephrine therapy [NE time]). Targeted metabolomic profiling Metabolite concentrations were measured on a SCIEX 5500 QTrapTM mass spectrometer (SCIEX, Darmstadt, Germany) using the MxP Quant 500XL kit (Biocrates, Life Sciences AG, Innsbruck, Austria). The kit combines flow injection analysis tandem mass spectrometry (FIA-MS/MS) for lipids and liquid chromatography tandem mass spectrometry (LC-MS/MS) using Agilent 1290 Infinity II liquid chromatography (Santa Clara, CA, USA) coupled with a tandem mass spectrometer for small molecules. Depending on the sample to be analyzed, this kit allows the quantification of up to 1019 metabolites: alkaloids (1), amine oxides (1), amino acids (20), amino acid related molecules (30), bile acids (14), biogenic amines (9), carboxylic acids (7), cresols (1), fatty acids (12), hormones and related metabolites (4), indoles and derivatives (4), nucleobases and related metabolites (2), vitamins and cofactors (1), carbohydrates and related metabolites (1), acylcarnitines (40), lysophosphatidic acids (8), phosphatidic acids (41), lysophosphatidylcholines (12), phosphatidylcholines (76), lysophosphatidylethanolamines (43), phosphatidylethanolamines (95), lysophophatidylglycerols (10), phosphatidylglycerols (64), lysophosphatidylinositols (16), phosphatidylinositols (53), lysophosphatidylserines (12), phosphatidylserines (18), sphinganines and sphingosines (8), sphinganine and sphingosine phosphates (8), sphingomyelines (15), ceramides (29), dihydroceramides (8), glycosylceramides (34), cholesterol esters (22), monoglycerides (12), diglycerides (44), and triglycerides (242). Metabolite extraction and all analytical assays were conducted in accordance with the protocols provided by the manufacturer ( https://biocrates.com/mxp-quant-500-xl/ , accessed on 02 Mai 2024). The WebIDQ ™ software tool (Biocrates Life Science AG, Innsbruck, Austria) was used for peak integration and to calculate metabolite concentrations. Quality screen The samples were measured on three 96 well plates. To assess metabolic changes as accurately as possible, all metabolites were included in the analyses except for those with a constant value across all samples in the respective comparison. 51, 49 and 52 metabolites were excluded when comparing d1 vs. d0, d3 vs. d0 and d7 vs. d0 respectively. Table S1 shows a complete list of included metabolites in each comparison. Any concentrations that were measured below limit of detection (LOD) were replaced with the pseudovalue LOD/2. Statistical analyses Due to non-normal distribution of the data, nonparametric statistical tests were employed. For principal component analysis (PCA), data were log10 transformed to correct for heteroscedasticity and auto-scaled to make all variables equally important. 26 Statistical Analysis of Metabolomics Data. University of North Carolina at Charlotte; Department of Bioinformatics & Genomics. Retrieved April 21, 2024, from https://www.uab.edu/proteomics/metabolomics/workshop/2014/statistical%20analysis.pdf ). Mean Euclidian distances were calculated for each metabolite class based on the first two principal components of the PCAs in the respective comparison to assess the metabolite classes with the greatest degree of change. Differential abundance analysis was performed using the Wilcoxon rank sum test to assess significance of differences between groups based on paired samples. The Benjamini-Hochberg correction was implemented with a false discovery rate (FDR) of 0.05 to account for multiple testing. For paired analysis, fold change (FC) was determined by calculating the ratio between paired samples, resulting in one FC per pair. The means of these FC values, pair means, was then computed. A FC threshold of ≥|1.5| was set for differential abundance analysis. Spearman’s rank correlation coefficient was used to assess correlations. PCA, differential abundance analysis, and correlation testing were performed using the open-source software MetaboAnalyst 5.0 ( https://www.metaboanalyst.ca/ ). Values for standard parameters that were <LOD were replaced by LOD/2: i.e., CRP LOD = 0.6 mg/l, was replaced with 0.3 mg/L. RESULTS Patient cohort Demographic and clinical characteristics of the patient cohort are summarized in Tables 1 and 2 . There was the expected preponderance of male patients and high proportion of patients with comorbidities which confer an increased cardiac risk (diabetes, overweight, COPD) ( Table 1 ). Most patients presented for bypass surgery for 3 or more coronary vessels, and the recorded values for bypass time, need for vasopressors, and length of ICU stay fell into the expected range. Postoperatively, there was a transient increase in creatine kinase (indicating cardiac ischemia), but renal and liver function parameters remained stable ( Table 2 ). There were no significant sex-specific differences except a higher blood leukocyte count in women on post-op day 3 (12.1 (10.1-14.8) vs. 9.6 (7.13-13.5), p = 0.024). Median CRP values rose greatly, manifesting the typical peak on day 3 and subsequent decline, but the median value of 59.5 mg/dL on d7 indicated ongoing systemic inflammation. In contrast, the marked leukocytosis on d1 essentially normalized by d7. Taken together, these data suggest that the patient cohort has the typical clinical characteristics of individuals presenting for elective coronary bypass graft surgery and manifests the expected postoperative evolution of inflammatory parameters. View this table: View inline View popup Download powerpoint Table 1. Baseline and intra-operative characteristics View this table: View inline View popup Download powerpoint Table 2. Hematologic and clinical chemistry parameters Postoperative changes in metabolite populations A PCA was performed to assess global differences in metabolite populations at each of the 3 post-operative time points (d1, d3, d7) with respect to the preoperative samples (d0). While substantial separation was already evident on d1, it increased further by d3 and persisted through d7. However, variance shifted from PC1 to PC2 on d7, indicating that it was driven, in part, by different metabolites than at the earlier time points. At all three time points, the greatest degree of variance with respect to d0 was due to alterations in triglyceride (TG) concentrations. For instance, the 20 analytes with the greatest contribution to variance in the first component (PC1, which contributed 17-23.5 % of overall variance) were TGs at all-time points, indicating a considerable degree of coregulation within this analyte class ( Figure 1A-C , Table S2) . Regarding PC2, PA and PG contributed most to variance at all-time points, peaking on d3 and decreasing on d7. TG impacted on PC2 only on d1. MG and LPEs contributed to variance in PC2 only on d7, largely explaining the separation between d0 and d7 samples along PC2 at this time point. Download figure Open in new tab Figure 1. Global and class-specific changes in metabolite populations at the three time points post-op. A principal component analysis (PCA) was performed using 968, 970 and 967 metabolites that passed quality assessment for the comparisons d1 vs. d0, d3 vs. d0 and d7 vs. d0, respectively (Table S1). The degree of reprogramming within individual metabolite classes was additionally assessed by Euclidian distance analysis. Total patient numbers (N) = 24 with four time points/patient, where N = 24 (d0); 24 (d1); 24 (d3); 20 (d7). A-C, PCA; D, Euclidian distance analysis. A complete list of Euclidian distances across all metabolite classes and the abbreviations used is contained in Table S3 . An Euclidian distance analysis supported the above notion that the greatest changes in metabolite populations occurred by d1 and d3, whereby the greatest changes were seen in lysoPEs, PEs, TGs, MGs, PC, PAs, lysoPC, and bile acids. The latter stood out in that there was a marked increase in variance on d1, which decreased by d3 and essentially normalized by d7. Nonetheless, several metabolite classes showed the largest Euclidian distance on d7. These were characterized by, overall, moderate Euclidian distances on d1 and d3 (e.g., LPI, FA, LPS, Cer), underscoring the differences in metabolite populations on day 7 compared to d1 and d3. A hierarchical clustering analysis based on the 100 most differentially abundant metabolites revealed a high degree of separation between the pre- and post-operative samples at all three time points, whereby all postoperative samples clustered in their own clade only on d1 ( Figure 2 , Figures S1 ). There was an overall tendency towards lower analyte concentrations on d1, but MGs constituted a notable exception in that concentrations of the three MG among these 100 analytes were higher post-op. Furthermore, this analysis revealed a strong coregulation of metabolites within one class, es exemplified by the clades 1-4, marked by a red circle, containing mostly BA (clade 1), TG (clade 2), PC/LPC (clade 3), and PE (clade 4). Co- regulation within metabolite classes (particularly within PS, PI, PG, PE, PA, TG, LPC, CE, BA, and AA) is also evident in a matrix based on correlations among all metabolites ( Figure S2) . This analysis also revealed between-class correlations, for instance of PI with PG and PA and of TG with PC, a subgroup of LPC, and DG. Download figure Open in new tab Figure 2. Differences in metabolite concentrations distinguish nearly perfectly between d0 and d1 samples. The 100 most significant (FDR obtained with t-test = 1.3e -9 – 5.86e -5 ) differentially abundant metabolites were selected by Euclidean distance for d1 with respect to d0 and subjected to unsupervised hierarchical biclustering analysis. Each colored cell in the heatmap corresponds to the group average concentration of the analyte with respect to the mean-centered and divided by standard deviation of the analyte (z-score). Y-axis = metabolite dendrogram and N = 24 (d0) and 24 (d1). Differential abundance analysis Results of a differential abundance (FC ≥|1.5|, FDR <0.05) analysis are visualized in Figure 3 and summarized in Table 3 . As seen in the volcano plots ( Figure 3A-C ) and Figure S3 there was a trend towards higher p values and FC (log10) values from d1 to d7. The highest number of differentially abundant metabolites was observed on d3, but even on d7 there were still 154 differentially abundant metabolites. Overall, most of the differentially abundant metabolites were downregulated. However, the number of downregulated metabolites decreased throughout the time course, whereas the number of upregulated metabolites increased, which resulted in a slight preponderance of upregulated vs. downregulated metabolites by d7 ( Table 3 ). Download figure Open in new tab Figure 3. Differential abundance analysis based on the same metabolites as figure 1 reveals a shift from down- to upregulation during post-operative recovery. Differentially abundant (FC ≥|1.5|, FDR <0.05 obtained with Wilcoxon rank-sum test) metabolites with respect to d0 are indicated for each time point post-op. For each day, a volcano plot indicating differential abundance of individual metabolites and a bar chart indicating the direction of abundance change in each metabolite class are shown. Blue bars = downregulation; red bars = upregulation. A,D, d1. B,E , d3. C,F , d7 and N = 24 (d0); 24 (d1); 24 (d3); 20 (d7). View this table: View inline View popup Download powerpoint Table 3. Number (%) of differentially abundant metabolites post-op Metabolite classes could be grouped into two kinetic patterns: those that were consistently downregulated (TG, BA, CE, ID) and those that were consistently upregulated (FA and MG) ( Figure 3D-F , Figure 4 , Figure S4 and 5 ). Notably, all BA were downregulated on d1 and 35, 7 % remained downregulated more than 1.5-fold on d3 and d7. Likewise, LPC and ID were consistently downregulated. Downregulation of TG was most pronounced on d3 (66%), but nearly normalized by d7. Substantial persistent upregulation was observed with FA and MG. Of the metabolite groups with few or only a single member, substantial downregulation of three metabolites was noted. (i) Concentrations of the alkaloid trigenolline were very low on d1 and reached only about 25% of pre-op levels by d7. Trigenolline is found in foods, notably in coffee beans, where it makes up about 1% and can also originate from gut microflora 27 . (ii) Similar downregulation was observed with trimethylamine N-oxide (TMAO), which can originate from gut microbiota or hepatic metabolism of trimethylamine. TMAO is closely related to the so called “western diet”, which is rich in choline and carnitine, and is associated with cardiovascular disease. 28 (iii) 3-IAA is a Trp metabolite which is a common growth hormone in plants, but also an intermediate of Trp catabolism in humans. Thus, the initially low, but then rising plasma levels of trigenolline and TMAO likely reflect absence of oral alimentation on d1, and the gradual resumption of an oral diet thereafter. There was a mild-to-moderate increase in cortisol post-op (indicating a physiologic stress response), whereas cortisone levels did not increase. Download figure Open in new tab Figure 4. Kinetics of concentration changes in selected metabolite classes and blood inflammatory parameters throughout the time course. Concentration dynamics are expressed as fold change with respect to d0. A, Blood CRP and leukocyte count. B-H, Plasma metabolites. B-E , Selected predominantly downregulated metabolite classes (bile acids n = 13, triglycerides n = 238, cholesterol esters n = 22, indoles and derivatives n = 3). F,G, Selected predominantly upregulated metabolite classes (fatty acids n = 8, monoglycerides n = 11). H , Selected individual metabolites of interest (trigonelline, TMAO, cortisol, cortisone, DHEAS). Days on which fold change was significant with respect to d0 are indicated as superscripts. N = 24 (d0); 24 (d1); 24 (d3); 20 (d7). Correlations between clinical parameters and metabolites We then aimed to identify clinical parameters that are most closely associated with changes in metabolite abundance and can be considered the main drivers of the marked metabolic alterations post-op. Among the intra-operative variables, the most significant correlations with metabolites at all three time points were observed for NE time, CPB time, and E/Dob time ( Figure 5A , Figure S6, Table 4 ). However, most significant correlation coefficients were of only modest strength, ranging between 0.25-0.5. On the other hand, substantially stronger correlations were observed between the markers of inflammation (CRP and leucocyte count) and metabolites, indicating that systemic inflammation is a strong, but certainly not the only, driver of the observed metabolite alterations. We then tested whether we could identify intra-operative parameters responsible for the observed systemic inflammation. However, the only significant correlation with inflammation was between ALAT and leukocytes ( r = -0.41, p = 0.0006) ( Figure 5B ). Download figure Open in new tab Figure 5. Correlations between intra-operative parameters, inflammation markers, and metabolites, based on Spearman rank coefficients. A , Correlation with metabolites, pooled analysis of data from all three time points combined. Each circle indicates one metabolite. Given metabolites represent the ones with highest correlation coefficient. Grey fill color = p > 0.05. B, Correlations among intra-operative parameters (n = 5), inflammation markers (n = 2), and clinical chemistry parameters (n = 6). * = p < 0.05. P values based on FDR obtained with t-test. N = 24 (d0); 24 (d1); 24 (d3); 20 (d7). View this table: View inline View popup Download powerpoint Table 4. Number of significant correlations ( p ≤0.05) between metabolites and clinical parameters DISCUSSION Our study is the first to show significant plasma metabolite changes after CABG in both acute and recovery phase, distinguishing it from similar studies. 29 , 30 Although changes in metabolites were evident during the acute phase and normalized during the recovery phase, intriguingly, there were few metabolite classes, belonging to the lipid, bile acid, and Trp derivatives, which exhibited a steady kinetic pattern throughout our investigations. Notably, plasma TG levels were significantly downregulated and were associated with increases in both MG and FA, suggesting perioperative modulation in lipid metabolism. Such alterations in metabolites could occur due to several plausible factors, including surgical trauma- associated inflammatory milieu, fasting, catecholamine-induced lipolysis, and heparin treatment. Of note, disturbances in gut microbiota community also play a significant role in inducing changes in metabolite profiles. 31 Increased systemic inflammation is a well-known consequence of CABG, in the process of which macrophages with inflammatory high phenotype tend to accumulate plasma-circulating TG, by either endocytosis or receptor-mediated internalization. 32 Such TG-laden inflammatory macrophages exhibit reduced capacity for lipolysis, which further lowers the inflammatory attributes of macrophages associated with increased mitochondrial dysfunction, decreased ability to polarize, migrate, 33 and phagocytose, and reduced PGE2 production. 34 This suggests a negative feedback loop to minimize the inflammatory state of these macrophages upon intracellular TG accumulation and could explain the reduced post- operative plasma TG levels. On the other hand, TG, CE, and PC accumulate in intracellular lipid droplets as cells respond to stress. 35 – 37 In our cohort, surgery-induced acute stress could promote lipid droplet turnover to compensate the energy and redox imbalances, where TG are constantly being hydrolyzed (via lipolysis or lipophagy) to convert into free FA and MG, 38 as reflected by their consistent upregulation in postoperative CAD circulation. Of note, CE- mediated lipid droplet nucleation is facilitated by these intracellular accumulated TG, since reduced plasma CE were also evident in our cohort. 39 Another contributing factor is the state of fasting, where the entire patient cohort remained fasting ≥6 hours prior to surgery until an oral diet was resumed on the first postoperative day. In addition to cardiac surgery stress, 40 this nutrient stress also triggers the sympathetic nervous system 41 to secrete catecholamines (norepinephrine) that activate lipolysis to satisfy the cellular energy demand, by promoting the breakdown of stored TG into FA and MG. Furthermore, every patient received high-dose intravenous (IV) unfractionated heparin (400 IU/kg body weight) before commencement of extracorporeal circulation, followed by low- dose prophylactic therapy until discharge. Since IV administered heparin rapidly increases lipid hydrolyzing enzymes (lipoprotein lipase), there could be a massive hydrolysis of TG into FA and MG. 42 Likewise, the entire patient cohort were uniformly treated with opioids, as peri- and post-operative pain management medications. Opioid could be regarded as a significant driving factor for changing cellular metabolism. 43 In line with this, the opioid doses could tend to increase cellular lipolytic activity, which could also, in part, generate FA 44 and MG from intracellular TG deposits to counterbalance increased cellular energy expenditure. 45 PC, as predominant class of plasma lipids, were consistently decreased in circulation, possibly due to their role in lipid droplet biogenesis 46 for high-energy supply during surgery- induced inflammation. Another explanation could be PC uptake via the CD36 scavenger receptor, increasing the cellular PC pool in differentiating macrophages, which may accelerate PC turnover and amplify inflammation. 47 Additionally, monocytes, as macrophage precursors, feature a higher intracellular PC content, particularly with aging. 48 These concepts hold true in our cohort settings that are representative of an aged population together with ongoing post-surgical inflammation. We therefore propose that an increased demand for intracellular PC content might reflect decreased circulating PC in the blood stream. A study of plasma lipid changes in community-acquired pneumonia (CAP) reported lower PC concentrations during acute presentation, which normalized with clinical recovery. 49 These results agree well with ours, as acute CAP features pronounced systemic inflammation of a similar magnitude as our cohort. Interestingly, a reduced plasma PC/PE ratio has led to increased levels of NLRP3, an integral component of the inflammasome activation pathway, which promoted changes in left ventricle geometry among CAD patients with insulin resistance. 50 Since 50 % of our CAD patients have diabetes as comorbidity, a notable decrease in plasma PC/PE ratio could possibly pose an increased risk to these patients in terms of cardiac remodeling. Similar to our findings, plasma levels of PC were also reduced in patients with other chronic inflammatory diseases, such as Alzheimeŕs disease 51 and diabetic nephropathy, 52 where both plasma PC and PC-Os were inversely associated with renal-related clinical covariates (eGFR and Albuminuria), ESRD and all-cause mortality in diabetic nephropathy. 52 Sometimes, choline-deficient diet could also explain the reasons behind a sudden drop in plasma PC levels 53 , 54 among CAD patients. However, a significant decline in plasma lipids could explain an ongoing catabolism due to acute stress, 55 induced by surgical trauma. Further, these circulating PC might have sequestered by binding to structurally-altered CRP 56 due to massive inflammation. Since PC is further cleaved by phospholipase A2 activity to generate LPC, 8 we noticed substantially reduced plasma LPC in CAD patients, which could reflect a limited availability of its precursor molecule, PC, in the circulation. Similar to our findings, plasma LPC levels were decreased among patients with obesity and diabetes 57 as well as Alzheimeŕs patients with chronic inflammation. 58 Since LPC act as a carrier molecule for PUFAs, 58 a deficit of plasma LPC pool might limit supply of PUFA to vascular health, causing vascular dysfunction, 59 increased inflammation and all-cause mortality. 60 Several reports have shown alterations in gut microbiota composition following cardiac surgery together with CPB usage. 61 , 62 Such gut dysbiosis led to decreased LPC generation which was, in particular, associated with reduced colonization of Bacteriodes population, as investigated in chronic pathologies such as Alzheimeŕs disease 63 Furthermore, we speculate that there was increased ferroptosis with decreased plasma LPC 63 in our patient cohort, as iron accumulation and lipid peroxidation have been reported following cardiac surgical procedures, including the usage of CPB. 64 , 65 In line with the above-mentioned beneficial role of PC and LPC, our study shows a negative correlation between PC and PC-Os as well as LPC and acute inflammatory markers (CRP and leucocyte count) and the use of CPB during surgery, highlighting a possible role of PC and LPC in regulating ongoing inflammation. Changes in plasma bile acids were also noticed in our CAD cohort, where BA metabolites were consistently downregulated, especially on postoperative day 1 and 3. This could reflect limited generation of BA metabolites due to gut dysbiosis, 66 which was also evident in patients with other chronic inflammation like ulcerative colitis. 66 Hence, to this extent, there is a high likelihood for a surgical trauma-induced gut dysbiosis in decreasing circulating BA metabolites postoperatively CAD. In fact, increased BA concentrations in the circulation have been reported to modulate blood monocyte function upon specific activation of bile acid receptor (TGR5). These monocytes exhibit decreased phagocytic capacity and reduced production of pro-inflammatory cytokines 67 during bacterial infection. Nevertheless, bile receptor TGR5 agonism induces nitric oxide (NO) production and hampers the adhesion of circulating monocyte to vascular endothelium. 67 In line with these reports, we supposed whether bile acid synthesis was reduced or their bioavailability was diminished due to their consumption at cell-expressed receptor binding sites in our cohort. But, in our previous study, 68 we demonstrated IL-6 high producing blood mononuclear cells among postoperative CAD patients, explaining the existence of functional monocytes and therefore, the possibility for decreased BA synthesis. Thus, a deficit in bile acid production could pose an increased risk for amplified inflammation in our postoperative cohort. Intriguingly, BA were positively correlated with CRP in these patients, suggesting a counteracting role of bile acids to reduce ongoing inflammation. This notion was supported by a report showing that increased CRP levels in LPS-induced endotoxemia among healthy volunteers correlate with a rise in total BA concentration 69 where these increased circulating BA metabolites exhibited immunosuppressive properties. However, a functional relationship between CRP and circulating BA would be interesting to investigate in our CAD cohort. Interestingly, a study on the effect of fasting and refeeding on plasma BA metabolites in mice demonstrated that both primary and secondary BA were decreased during fasting and this condition was reversed upon refeeding. These alterations were largely associated with decreased abundance of BA-metabolizing Lactobacillus and Bifidobacterium in gut. In addition, the genes involved in hepatic BA synthesis (CYP7A1, CYP7B1, and AKR1D1) were repressed during the fasting state. However, BA metabolizing microbiota as well as hepatic BA synthesizing genes were expressed during re-feeding. 70 A similar mechanism might underlie the reduced plasma BA levels in our CAD patients, who were also in the state of fasting and gradual refeeding during the peri-and post-operative period. Next, a consistent downregulated pattern of indole derivatives (indole, 3-IAA, 3-IPA and Ind- SO 4 ) was noticed. These molecules are generated as Trp catabolites by the gut microbial community, 22 are absorbed by intestinal epithelium and enter the blood stream. They are particularly known to fortify intestinal epithelial barrier function, by increasing the expression of tight junctional proteins, and thereby to prevent leaky gut. 22 Post-surgical gut microbial dysbiosis could explain the reason for reduced plasma indole derivatives in our cohort. To support our findings, significantly reduced levels of indole derivatives, in particular 3-IAA and 3-IPA, have been reported in patients with severe atherosclerosis, 71 indicating their anti-inflammatory role. 72 Additionally, 3-IPA is known to enhance systemic homeostasis with the gut-multiorgan axis during acute systemic inflammation. 73 Although several indole derivatives promote inflammation-attenuating host responses, indole sulfate is considered to be the notable exception, which is a uremic toxin and accumulates in serum of chronic kidney disease patients. 74 In line with this and despite reduced levels of indole sulfate in our cohort, a positive correlation between indole sulfate and CBP time was noted, reflecting its possible role in oxidative stress. In addition to this, another Trp catabolite (kynurenine) and trigonelline were positively associated with CBP time. Due to their immune suppressive qualities, both kynurenine and trigonelline could be involved in regulating the stressful inflammatory milieu during cardiac surgery. However, specific functions of these metabolites should be investigated. Taken together, despite the limited number of CAD patients, our current study has demonstrated discrete changes in plasma metabolite populations during the postoperative period. Although we did not observe any distinct pattern of metabolite alterations observed with CBP usage, we presume that surgery-related acute inflammation, in general, plays a significant role in aberrant regulation of metabolites. According to the observation, an excessive generation of free fatty acids in our cohort could pose an increased severity to coronary atherosclerosis, especially among those who are comorbid with T2DM and obesity, 75 by inducing endothelial dysfunctions and defects in insulin signaling 76 and sensitivity. 77 Further PC supplementation as prophylactic measures might be an ideal option for CAD patients prior to cardiac surgery in order to compensate for reduced postoperative PC and LPC levels. A targeted investigation is needed to obtain data on gut microbial communities in CAD patients before and after surgery, especially during fasting and refeeding. A better understanding of depleted microbial taxa is essential to enrich the surgery-scheduled CAD patients with probiotics containing the target microbiota. Such microbial recolonization might benefit these patients to regulate ongoing acute inflammation by maintaining the levels of BA and indole derivatives, which were hampered in postoperative CAD patients. Moreover, a subsequent validation study in similar CAD settings would strengthen the validity of our findings. Data Availability Yes, the data will be available upon request FUNDINGS FP is supported by internal funds of the Helmholtz Centre for Infection Research, Braunschweig, Germany. FN is supported by Latvian State Scholarship, No.4.-10.3/3470. MW and PV are supported by internal research funds of the Otto-von-Guericke University Hospital, Magdeburg, Germany. AUTHOR CONTRIBUTION STATEMENTS FN was involved in concept development, experimentation, data analysis and manuscript drafting; MW was involved in concept development, blood sampling and clinical data handling, manuscript drafting; SS was involved in experimentation and manuscript proof-reading; SV was involved in blood sampling and manuscript proof-reading; GA was involved in blood sampling and manuscript proof-reading; JW was involved in manuscript proof-reading; FP provided funds and resources and was involved in concept development, data analysis, and manuscript drafting and finalizing; PV was involved in concept development, experimentation, manuscript drafting and finalizing. CONFLICT OF INTEREST The authors declare no conflict of interest relating to conduct of the study or publication of the manuscript. ACKNOWLEDGEMENTS We extend our thanks to Ms. Elena Denks for her excellent technical assistance, Esther Meyer for collecting patient blood and organizing the screening for patients, and Dr. Fakhar Waqas (TWINCORE) for support. REFERENCES 1. ↵ Caldonazo T , Kirov H , Riedel LL , Gaudino M , Doenst T . Comparing CABG and PCI across the globe based on current regional registry evidence . Scientific Reports 2022 ; 12 : 22164 . 2. ↵ Zamzami B , Alghamdi AA. Cardiopulmonary Bypass . In: Yelbuz TM , Bin-Moallim MA , Husain WJM , Alakeel YS , Kabbani MS , Alghamdi AA , eds. Manual of Pediatric Cardiac Care: Volume II . Singapore : Springer Nature Singapore , 2024 :33-35. 3. ↵ Lesouhaitier M , Belicard F , Tadié J-M . Cardiopulmonary bypass and VA-ECMO induced immune dysfunction: common features and differences, a narrative review . Critical Care 2024 ; 28 : 300 . 4. ↵ Ni Choileain N , Redmond HP . Cell Response to Surgery . Archives of Surgery 2006 ; 141 : 1132 – 1140 . OpenUrl CrossRef PubMed Web of Science 5. ↵ Viswan A , Ghosh P , Gupta D , Azim A , Sinha N . Distinct Metabolic Endotype Mirroring Acute Respiratory Distress Syndrome (ARDS) Subphenotype and its Heterogeneous Biology . Scientific Reports 2019 ; 9 :2108. 6. ↵ Zhu Q , Wu Y , Mai J , Guo G , Meng J , Fang X , Chen X , Liu C , Zhong S . Comprehensive Metabolic Profiling of Inflammation Indicated Key Roles of Glycerophospholipid and Arginine Metabolism in Coronary Artery Disease . Front Immunol 2022 ; 13 : 829425 . 7. ↵ Quehenberger O , Armando AM , Brown AH , Milne SB , Myers DS , Merrill AH , Bandyopadhyay S , Jones KN , Kelly S , Shaner RL , Sullards CM , Wang E , Murphy RC , Barkley RM , Leiker TJ , Raetz CRH , Guan Z , Laird GM , Six DA , Russell DW , McDonald JG , Subramaniam S , Fahy E , Dennis EA . Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] . Journal of Lipid Research 2010 ; 51 : 3299 – 3305 . OpenUrl Abstract / FREE Full Text 8. ↵ Law SH , Chan ML , Marathe GK , Parveen F , Chen CH , Ke LY . An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases . Int J Mol Sci 2019 ; 20 . 9. ↵ Wahlström A , Sayin SI , Marschall HU , Bäckhed F . Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism . Cell Metab 2016 ; 24 : 41 – 50 . OpenUrl CrossRef PubMed 10. ↵ Fleishman JS , Kumar S . Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets . Signal Transduction and Targeted Therapy 2024 ; 9 : 97 . 11. ↵ Li YTY , Swales KE , Thomas GJ , Warner TD , Bishop-Bailey D . Farnesoid X Receptor Ligands Inhibit Vascular Smooth Muscle Cell Inflammation and Migration. Arteriosclerosis , Thrombosis, and Vascular Biology 2007 ; 27 : 2606 – 2611 . OpenUrl 12. ↵ Porez G , Prawitt J , Gross B , Staels B . Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease: Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases . Journal of Lipid Research 2012 ; 53 : 1723 – 1737 . OpenUrl Abstract / FREE Full Text 13. ↵ de Vries HD , Eijgenraam TR , Bloks VW , Mulder NL , van Zutphen T , Silljé HHW , Kuipers F , de Boer JF . Elevated plasma bile acids coincide with cardiac stress and inflammation in young Cyp2c70−/− mice . Pediatric Research 2024 . 14. ↵ Yntema T , Koonen DPY , Kuipers F . Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases . Nutrients 2023 ; 15 . 15. ↵ Mayerhofer CCK , Ueland T , Broch K , Vincent RP , Cross GF , Dahl CP , Aukrust P , Gullestad L , Hov JR , Trøseid M . Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure . J Card Fail 2017 ; 23 : 666 – 671 . OpenUrl CrossRef PubMed 16. ↵ Feng X , Zhai G , Yang J , Liu Y , Zhou Y , Guo Q . Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids . Front Endocrinol (Lausanne ) 2021 ; 12 : 754006 . 17. ↵ Jrad-Lamine A , Henry-Berger J , Gourbeyre P , Damon-Soubeyrand C , Lenoir A , Combaret L , Saez F , Kocer A , Tone S , Fuchs D , Zhu W , Oefner PJ , Munn DH , Mellor AL , Gharbi N , Cadet R , Aitken RJ , Drevet JR . Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state . J Biol Chem 2011 ; 286 : 8030 – 8042 . OpenUrl Abstract / FREE Full Text 18. ↵ Pedersen ER , Svingen GFT , Schartum-Hansen H , Ueland PM , Ebbing M , Nordrehaug JE , Igland J , Seifert R , Nilsen RM , Nygård O . Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography . European Heart Journal 2013 ; 34 : 2689 – 2696 . OpenUrl CrossRef PubMed Web of Science 19. ↵ Zuo H , Ueland PM , Ulvik A , Eussen SJPM , Vollset SE , Nygård O , Midttun Ø , Theofylaktopoulou D , Meyer K , Tell GS . Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study . American Journal of Epidemiology 2016 ; 183 : 249 – 258 . OpenUrl CrossRef PubMed 20. ↵ Sinha AK , Laursen MF , Brinck JE , Rybtke ML , Hjørne AP , Procházková N , Pedersen M , Roager HM , Licht TR . Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota . Nature Microbiology 2024 ; 9 : 1964 – 1978 . OpenUrl PubMed 21. ↵ Veluswamy P , Wippermann J , Wacker M . Feeding the vasculature with cruciferous vegetables: a secret for organ protection . Signal Transduction and Targeted Therapy 2024 ; 9 : 36 . 22. ↵ Ye X , Li H , Anjum K , Zhong X , Miao S , Zheng G , Liu W , Li L . Dual Role of Indoles Derived From Intestinal Microbiota on Human Health . Front Immunol 2022 ; 13 : 903526 . 23. ↵ Gao H , Liu S . Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease . Life Sciences 2017 ; 185 : 23 – 29 . OpenUrl PubMed 24. ↵ Barreto FC , Barreto DV , Liabeuf S , Meert N , Glorieux G , Temmar M , Choukroun G , Vanholder R , Massy ZA . Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients . Clin J Am Soc Nephrol 2009 ; 4 : 1551 – 1558 . OpenUrl Abstract / FREE Full Text 25. ↵ Lin T-J , Hsu B-G , Wang J-H , Lai Y-H , Dongoran RA , Liu C-H . Serum indoxyl sulfate as a potential biomarker of aortic arterial stiffness in coronary artery disease. Nutrition , Metabolism and Cardiovascular Diseases 2020 ; 30 : 2320 – 2327 . OpenUrl 26. ↵ van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ . Centering, scaling, and transformations: improving the biological information content of metabolomics data . BMC Genomics 2006 ; 7 : 142 . 27. ↵ Li KJ , Brouwer-Brolsma EM , Burton-Pimentel KJ , Vergeres G , Feskens EJM . A systematic review to identify biomarkers of intake for fermented food products . Genes Nutr 2021 ; 16 : 5 . 28. ↵ Wang Z , Kaplan RC , Burk RD , Qi Q. The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease . Int J Mol Sci 2024 ; 25 . 29. ↵ Kirov H , Schwarzer M , Neugebauer S , Faerber G , Diab M , Doenst T . Metabolomic profiling in patients undergoing Off-Pump or On-Pump coronary artery bypass surgery . BMC Cardiovasc Disord 2017 ; 17 : 93 . 30. ↵ Bojko B , Wąsowicz M , Pawliszyn J . Metabolic profiling of plasma from cardiac surgical patients concurrently administered with tranexamic acid: DI-SPME-LC- MS analysis . J Pharm Anal 2014 ; 4 : 6 – 13 . OpenUrl PubMed 31. ↵ Hou K , Wu Z-X , Chen X-Y , Wang J-Q , Zhang D , Xiao C , Zhu D , Koya JB , Wei L , Li J , Chen Z-S . Microbiota in health and diseases . Signal Transduction and Targeted Therapy 2022 ; 7 : 135 . 32. ↵ Deng L , Kersten S , Stienstra R . Triacylglycerol uptake and handling by macrophages: From fatty acids to lipoproteins . Prog Lipid Res 2023 ; 92 : 101250 . 33. ↵ Aflaki E , Balenga NA , Luschnig-Schratl P , Wolinski H , Povoden S , Chandak PG , Bogner-Strauss JG , Eder S , Konya V , Kohlwein SD , Heinemann A , Kratky D . Impaired Rho GTPase activation abrogates cell polarization and migration in macrophages with defective lipolysis . Cell Mol Life Sci 2011 ; 68 : 3933 – 3947 . OpenUrl CrossRef PubMed 34. ↵ van Dierendonck X , Vrieling F , Smeehuijzen L , Deng L , Boogaard JP , Croes CA , Temmerman L , Wetzels S , Biessen E , Kersten S , Stienstra R . Triglyceride breakdown from lipid droplets regulates the inflammatory response in macrophages . Proc Natl Acad Sci U S A 2022 ; 119 : e2114739119 . OpenUrl CrossRef PubMed 35. ↵ Goldberg IJ , Reue K , Abumrad NA , Bickel PE , Cohen S , Fisher EA , Galis ZS , Granneman JG , Lewandowski ED , Murphy R , Olive M , Schaffer JE , Schwartz-Longacre L , Shulman GI , Walther TC , Chen J . Deciphering the Role of Lipid Droplets in Cardiovascular Disease . Circulation 2018 ; 138 : 305 – 315 . OpenUrl Abstract / FREE Full Text 36. van Dierendonck XAMH , Vrieling F , Smeehuijzen L , Deng L , Boogaard JP , Croes C-A , Temmerman L , Wetzels S , Biessen E , Kersten S , Stienstra R . Triglyceride breakdown from lipid droplets regulates the inflammatory response in macrophages . Proceedings of the National Academy of Sciences 2022 ; 119 : e2114739119 . OpenUrl CrossRef PubMed 37. ↵ Kuo A , Lee MY , Sessa WC . Lipid Droplet Biogenesis and Function in the Endothelium . Circulation Research 2017 ; 120 : 1289 – 1297 . OpenUrl Abstract / FREE Full Text 38. ↵ Borgström B , Tryding N , Westöö G. On the Extent of Hydrolysis of Triglyceride Ester Bonds in the Lumen of Human Small Intestine during Digestion . Acta Physiologica Scandinavica 1957 ; 40 : 241 – 247 . OpenUrl CrossRef PubMed 39. ↵ Dumesnil C , Vanharanta L , Prasanna X , Omrane M , Carpentier M , Bhapkar A , Enkavi G , Salo VT , Vattulainen I , Ikonen E , Thiam AR . Cholesterol esters form supercooled lipid droplets whose nucleation is facilitated by triacylglycerols . Nature Communications 2023 ; 14 : 915 . 40. ↵ Engelman RM , Haag B , Lemeshow S , Angelo A , Rousou JH . Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures . The Journal of Thoracic and Cardiovascular Surgery 1983 ; 86 : 608 – 615 . OpenUrl PubMed Web of Science 41. ↵ Landsberg L , Young JB. Fasting , Feeding and Regulation of the Sympathetic Nervous System . New England Journal of Medicine 1978 ; 298 : 1295 – 1301 . OpenUrl CrossRef PubMed Web of Science 42. ↵ Yang JY , Kim TK , Koo BS , Park BH , Park JW . Change of plasma lipoproteins by heparin-released lipoprotein lipase . Exp Mol Med 1999 ; 31 : 60 – 64 . OpenUrl PubMed 43. ↵ Tarazi D , Maynes JT . Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer . Pharmaceutics 2023 ; 15 . 44. ↵ Wong SC , Yeung YG , Yeung D . Acute and chronic effects of morphine on lipolysis in rat epididymal fat pads . Biochemical Pharmacology 1977 ; 26 : 143 – 147 . OpenUrl PubMed 45. ↵ Cone AL , Wu KK , Kravitz AV , Norris AJ. Kappa opioid receptor activation increases thermogenic energy expenditure which drives increased feeding . iScience 2023 ;26:107241. 46. ↵ Krahmer N , Guo Y , Wilfling F , Hilger M , Lingrell S , Heger K , Newman HW , Schmidt-Supprian M , Vance DE , Mann M , Farese RV , Jr. , Walther TC . Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase . Cell Metab 2011 ; 14 : 504 – 515 . OpenUrl CrossRef PubMed Web of Science 47. ↵ Petkevicius K , Virtue S , Bidault G , Jenkins B , Çubuk C , Morgantini C , Aouadi M , Dopazo J , Serlie MJ , Koulman A , Vidal-Puig A . Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity . Elife 2019 ; 8 . 48. ↵ Saare M , Tserel L , Haljasmägi L , Taalberg E , Peet N , Eimre M , Vetik R , Kingo K , Saks K , Tamm R , Milani L , Kisand K , Peterson P . Monocytes present age-related changes in phospholipid concentration and decreased energy metabolism . Aging Cell 2020 ; 19 : e13127 . OpenUrl CrossRef PubMed 49. ↵ Arshad H , Alfonso JCL , Franke R , Michaelis K , Araujo L , Habib A , Zboromyrska Y , Lücke E , Strungaru E , Akmatov MK , Hatzikirou H , Meyer-Hermann M , Petersmann A , Nauck M , Brönstrup M , Bilitewski U , Abel L , Sievers J , Vila J , Illig T , Schreiber J , Pessler F . Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia . Journal of Translational Medicine 2019 ; 17 : 365 . 50. ↵ Vianello E , Ambrogi F , Kalousová M , Badalyan J , Dozio E , Tacchini L , Schmitz G , Zima T , Tsongalis GJ , Corsi-Romanelli MM . Circulating perturbation of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) is associated to cardiac remodeling and NLRP3 inflammasome in cardiovascular patients with insulin resistance risk . Exp Mol Pathol 2024 ; 137 : 104895 . 51. ↵ Whiley L , Sen A , Heaton J , Proitsi P , García-Gómez D , Leung R , Smith N , Thambisetty M , Kloszewska I , Mecocci P , Soininen H , Tsolaki M , Vellas B , Lovestone S , Legido-Quigley C . Evidence of altered phosphatidylcholine metabolism in Alzheimer’s disease . Neurobiol Aging 2014 ; 35 : 271 – 278 . OpenUrl CrossRef PubMed 52. ↵ Tofte N , Suvitaival T , Ahonen L , Winther SA , Theilade S , Frimodt-Møller M , Ahluwalia TS , Rossing P . Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes . Sci Rep 2019 ; 9 : 16398 . 53. ↵ da Costa KA , Niculescu MD , Craciunescu CN , Fischer LM , Zeisel SH . Choline deficiency increases lymphocyte apoptosis and DNA damage in humans . Am J Clin Nutr 2006 ; 84 : 88 – 94 . OpenUrl Abstract / FREE Full Text 54. ↵ Zeisel SH , Da Costa KA , Franklin PD , Alexander EA , Lamont JT , Sheard NF , Beiser A . Choline, an essential nutrient for humans . Faseb j 1991 ; 5 : 2093 – 2098 . OpenUrl CrossRef PubMed Web of Science 55. ↵ Wu J , Cyr A , Gruen DS , Lovelace TC , Benos PV , Das J , Kar UK , Chen T , Guyette FX , Yazer MH , Daley BJ , Miller RS , Harbrecht BG , Claridge JA , Phelan HA , Zuckerbraun BS , Neal MD , Johansson PI , Stensballe J , Namas RA , Vodovotz Y , Sperry JL , Billiar TR . Lipidomic signatures align with inflammatory patterns and outcomes in critical illness . Nat Commun 2022 ; 13 :6789. 56. ↵ Pathak A , Singh SK , Thewke DP , Agrawal A . Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis . Front Immunol 2020 ; 11 :1780. 57. ↵ Barber MN , Risis S , Yang C , Meikle PJ , Staples M , Febbraio MA , Bruce CR . Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes . PLoS One 2012 ; 7 : e41456 . OpenUrl CrossRef PubMed 58. ↵ Semba RD . Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease . Adv Nutr 2020 ; 11 : 760 – 772 . OpenUrl CrossRef PubMed 59. ↵ Wiest EF , Walsh-Wilcox MT , Walker MK . Omega-3 Polyunsaturated Fatty Acids Protect Against Cigarette Smoke-Induced Oxidative Stress and Vascular Dysfunction . Toxicological Sciences 2017 ; 156 : 300 – 310 . OpenUrl PubMed 60. ↵ Colussi G , Catena C , Novello M , Bertin N , Sechi LA . Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes. Nutrition , Metabolism and Cardiovascular Diseases 2017 ; 27 : 191 – 200 . OpenUrl 61. ↵ Maekawa M , Yoshitani K , Yahagi M , Asahara T , Shishido Y , Fukushima S , Tadokoro N , Fujita T , Ohnishi Y . Association between postoperative changes in the gut microbiota and pseudopsia after cardiac surgery: prospective observational study . BMC Surg 2020 ; 20 : 247 . 62. ↵ Zhang Y , Luo W , Zhao M , Li Y , Wu X . Advances in understanding the effects of cardiopulmonary bypass on gut microbiota during cardiac surgery . The International Journal of Artificial Organs 2025 ; 48 : 51 – 63 . OpenUrl PubMed 63. ↵ Zha X , Liu X , Wei M , Huang H , Cao J , Liu S , Bian X , Zhang Y , Xiao F , Xie Y , Wang W , Zhang C . Microbiota-derived lysophosphatidylcholine alleviates Alzheimer’s disease pathology via suppressing ferroptosis . Cell Metab 2025 ; 37 : 169 – 186 .e169. OpenUrl PubMed 64. ↵ Mumby S , Koh TW , Pepper JR , Gutteridge JMC . Risk of iron overload is decreased in beating heart coronary artery surgery compared to conventional bypass . Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2001 ;1537: 204 – 210 . 65. ↵ Hadjinikolaou L , Alexiou C , Cohen AS , Standbridge RDL , McColl AJ , Richmond W . Early changes in plasma antioxidant and lipid peroxidation levels following coronary artery bypass surgery: a complex response . European Journal of Cardio-Thoracic Surgery 2003 ; 23 : 969 – 975 . OpenUrl CrossRef PubMed 66. ↵ Sinha SR , Haileselassie Y , Nguyen LP , Tropini C , Wang M , Becker LS , Sim D , Jarr K , Spear ET , Singh G , Namkoong H , Bittinger K , Fischbach MA , Sonnenburg JL , Habtezion A . Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation . Cell Host Microbe 2020 ; 27 : 659 – 670 .e655. OpenUrl CrossRef PubMed 67. ↵ Leonhardt J , Haider RS , Sponholz C , Leonhardt S , Drube J , Spengler K , Mihaylov D , Neugebauer S , Kiehntopf M , Lambert NA , Kortgen A , Bruns T , Tacke F , Hoffmann C , Bauer M , Heller R . Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction . Cell Mol Gastroenterol Hepatol 2021 ; 12 : 25 – 40 . OpenUrl PubMed 68. ↵ Wacker M , Ball A , Beer HD , Schmitz I , Borucki K , Azizzadeh F , Scherner M , Awad G , Wippermann J , Veluswamy P . Immunophenotyping of Monocyte Migration Markers and Therapeutic Effects of Selenium on IL-6 and IL-1β Cytokine Axes of Blood Mononuclear Cells in Preoperative and Postoperative Coronary Artery Disease Patients . Int J Mol Sci 2023 ; 24 . 69. ↵ Leonhardt J , Dorresteijn MJ , Neugebauer S , Mihaylov D , Kunze J , Rubio I , Hohberger FS , Leonhardt S , Kiehntopf M , Stahl K , Bode C , David S , Wagener F , Pickkers P , Bauer M . Immunosuppressive effects of circulating bile acids in human endotoxemia and septic shock: patients with liver failure are at risk . Crit Care 2023 ; 27 : 372 . 70. ↵ Zhang Y , Qi H , Wang L , Hu C , Gao A , Wu Q , Wang Q , Lin H , Chen B , Wang X , Wang S , Lin H , Wang W , Bi Y , Wang J , Lu J , Liu R . Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota . J Diabetes 2023 ; 15 : 165 – 180 . OpenUrl PubMed 71. ↵ Cason CA , Dolan KT , Sharma G , Tao M , Kulkarni R , Helenowski IB , Doane BM , Avram MJ , McDermott MM , Chang EB , Ozaki CK , Ho KJ . Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes . J Vasc Surg 2018 ; 68 : 1552 – 1562 .e1557. OpenUrl CrossRef PubMed 72. ↵ Zhuang H , Ren X , Jiang F , Zhou P . Indole-3-propionic acid alleviates chondrocytes inflammation and osteoarthritis via the AhR/NF-κB axis . Mol Med 2023 ; 29 : 17 . 73. ↵ Jiang H , Chen C , Gao J . Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease . Nutrients 2022 ; 15 . 74. ↵ Meijers BK , Evenepoel P . The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression . Nephrol Dial Transplant 2011 ; 26 : 759 – 761 . OpenUrl CrossRef PubMed Web of Science 75. ↵ Xin Y , Zhang J , Fan Y , Wang C . Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study . BMC Cardiovasc Disord 2021 ; 21 : 343 . 76. ↵ Ghosh A , Gao L , Thakur A , Siu PM , Lai CWK . Role of free fatty acids in endothelial dysfunction . J Biomed Sci 2017 ; 24 : 50 . 77. ↵ Chueire VB , Muscelli E . Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect - a narrative review . Arch Endocrinol Metab 2021 ; 65 : 24 – 31 . OpenUrl PubMed View the discussion thread. Back to top Previous Next Posted April 13, 2025. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Altered plasma metabolites as fingerprint of cardiac bypass surgery Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Altered plasma metabolites as fingerprint of cardiac bypass surgery Frieder Neu , Max Wacker , Sven Schuchardt , Sam Vargese , George Awad , Jens Wippermann , Frank Peßler , Priya Veluswamy medRxiv 2025.04.11.25325708; doi: https://doi.org/10.1101/2025.04.11.25325708 Share This Article: Copy Citation Tools Altered plasma metabolites as fingerprint of cardiac bypass surgery Frieder Neu , Max Wacker , Sven Schuchardt , Sam Vargese , George Awad , Jens Wippermann , Frank Peßler , Priya Veluswamy medRxiv 2025.04.11.25325708; doi: https://doi.org/10.1101/2025.04.11.25325708 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Cardiovascular Medicine Subject Areas All Articles Addiction Medicine (568) Allergy and Immunology (863) Anesthesia (300) Cardiovascular Medicine (4435) Dentistry and Oral Medicine (444) Dermatology (382) Emergency Medicine (608) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1509) Epidemiology (15227) Forensic Medicine (30) Gastroenterology (1124) Genetic and Genomic Medicine (6597) Geriatric Medicine (668) Health Economics (997) Health Informatics (4534) Health Policy (1368) Health Systems and Quality Improvement (1613) Hematology (540) HIV/AIDS (1264) Infectious Diseases (except HIV/AIDS) (15916) Intensive Care and Critical Care Medicine (1103) Medical Education (623) Medical Ethics (146) Nephrology (667) Neurology (6599) Nursing (346) Nutrition (998) Obstetrics and Gynecology (1144) Occupational and Environmental Health (957) Oncology (3332) Ophthalmology (974) Orthopedics (369) Otolaryngology (420) Pain Medicine (436) Palliative Medicine (130) Pathology (663) Pediatrics (1693) Pharmacology and Therapeutics (691) Primary Care Research (711) Psychiatry and Clinical Psychology (5447) Public and Global Health (9230) Radiology and Imaging (2198) Rehabilitation Medicine and Physical Therapy (1370) Respiratory Medicine (1196) Rheumatology (593) Sexual and Reproductive Health (712) Sports Medicine (530) Surgery (712) Toxicology (99) Transplantation (289) Urology (265) (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'a002bbccacfe0704',t:'MTc3OTUyNTM5Mw=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.